A detailed history of New Edge Advisors, LLC transactions in Natera, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 1,307 shares of NTRA stock, worth $212,243. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,307
Previous 1,563 16.38%
Holding current value
$212,243
Previous $169,000 1.78%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $25,024 - $33,195
-256 Reduced 16.38%
1,307 $166,000
Q2 2024

Aug 15, 2024

SELL
$85.28 - $112.6 $56,540 - $74,653
-663 Reduced 29.78%
1,563 $169,000
Q1 2024

May 14, 2024

BUY
$59.21 - $92.9 $121,498 - $190,630
2,052 Added 1179.31%
2,226 $203,000
Q4 2023

Feb 13, 2024

BUY
$37.55 - $62.64 $5,144 - $8,581
137 Added 370.27%
174 $10,000
Q2 2023

Aug 14, 2023

SELL
$47.08 - $55.16 $50,140 - $58,745
-1,065 Reduced 96.64%
37 $1,000
Q1 2023

May 12, 2023

SELL
$36.57 - $58.29 $6,070 - $9,676
-166 Reduced 13.09%
1,102 $61,000
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $43,327 - $60,749
1,268 New
1,268 $50,000
Q1 2022

May 13, 2022

SELL
$30.32 - $91.33 $65,127 - $196,176
-2,148 Closed
0 $0
Q4 2021

Feb 17, 2022

SELL
$86.26 - $119.0 $1.75 Million - $2.41 Million
-20,293 Reduced 90.43%
2,148 $201,000
Q3 2021

Oct 29, 2021

SELL
$100.17 - $126.36 $357,907 - $451,484
-3,573 Reduced 13.73%
22,441 $2.5 Million
Q2 2021

Jul 22, 2021

BUY
$86.05 - $119.72 $485,149 - $674,981
5,638 Added 27.67%
26,014 $2.95 Million
Q1 2021

Apr 26, 2021

BUY
$91.47 - $124.36 $1.28 Million - $1.74 Million
13,994 Added 219.27%
20,376 $2.07 Million
Q4 2020

Jan 27, 2021

BUY
$66.66 - $111.74 $183,781 - $308,067
2,757 Added 76.06%
6,382 $635,000
Q3 2020

Nov 03, 2020

SELL
$45.89 - $72.67 $41,805 - $66,202
-911 Reduced 20.08%
3,625 $262,000
Q2 2020

Jul 29, 2020

BUY
$26.36 - $49.86 $119,568 - $226,164
4,536 New
4,536 $226,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.